Dynamics and phases of changes in the primary focus of Morris hepatoma under local application of cytokine hrecTNF-α

Neoplasma

Volumn 43, Issue 2, 1996, Pages 125-132

  Terlikowski, S ^a   Nowak, H Fr ^a   Lotocki, W ^a  

^a Medical School   (Poland)

Author keywords

human recombinant tumor necrosis factor (hrecTNF ); immunotherapy; Morris hepatoma 5123; tumor growth

Indexed keywords

RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY MASS; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; FEMALE; HISTOLOGY; INTRATUMORAL DRUG ADMINISTRATION; MORRIS HEPATOMA; NONHUMAN; RAT; TUMOR GROWTH;

EID: 0029946773     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. AGGARWAL, S.B., KOHN, W.J., HASS, P.E., MOFFAT, B., SPENCER, S.A., HENZEL, W.J., BRINGMAN, T.S., NEDWIN, G.E., GOEDDEL, D.V., HARKINS, R.N.: Human tumor necrosis factor: Production, purification and characterization. J. Biol. Chem., 260, 1985, 2345-2354.
2. CARSWELL, E.A., OLD, L.J., KASSEL, R.L., GREEN, S., FIORE, N., WILLIAMSON, B.: An endotoxin induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA, 72, 1975, 3666-3670.
3. CIANO, P.S., COLVIN, R.B., DVORAK, A.M., MCDONAGH, J., DVORAK, H.F.: Macrophage migration in fibrin gel matrices. Lab.Invest., 54, 1986, 62-70.
4. DVORAK, H.F., HARVEY, V.S., ESTRELLA, P., MCDONAGH, J., DVORAK, A.M.: Fibrin containing gel induce angiogenesis: Implications for tumor stroma generation and wound healing. Lab. Invest., 57, 1987, 673-686.
5. FAJARDO, L.F., KWAN, H.H., KOWALSKI, J., PRIONAS, S.D., ALLISON, A.C.: Dual role of tumor necrosis factor-α in angiogenesis. Am. J. Pathol., 140, 1992, 539-544.
6. FICHTNER, I., LEMM, M., BECKER, M., TANNEBERGER, S.: Determination of antineoplastic activity and toxicity of tumor necrosis factor (TNF) in animal experiments. Correlation to clinical findings. Neoplasma, 37, 1990, 301-315.
7. GILLIS, S.: Cytokine receptors. Curr. Opinion Immunol., 3, 1991, 315-319.
8. KLYSIK, J., KONARZEWSKA-ZGLINSKA, A., GALAZJA, G., UZNANSKI, B., OKRUSZEK, A., GUGA, P., WILK, A., KOZIOLKIEWICZ, M., TCHORZEWSKI, H., ZEMBALA, M., STEC, W.J.: Synthesis and expression in E.coli of the gene for tumor necrosis factor (hαTNF). Arch. Immunol. Ther. Exp., 39, 1991, 349-355.
9. MCINTOSH, J.K., MULE, I.J., TRAVIS, W.D., HOSENBERG, S.A.: Studies of effects of recombinant human tumor necrosis factor on autochthonous tumor and transplanted normal tissue in mice. Cancer Res., 50, 1990, 2463-2469.
10. NAREDI, P.L., LINDNER, P.G., HOLMHERG, S.B., STENRAM, U., PETERSON, A., HAFSTROM, L.R.: The effects of tumor necrosis factor alpha on the vascular bed and blood flow in an experimental rat hepatoma. Int. J. Cancer, 54, 1993, 645-649.
11. NISHIZAWA, T., OKUTOMI, T., INAGAWA, H., MORIKAWA, A., OSHIMA, H., SOMA, G., MIZUNO, D.: Intratumoral tumor necrosis factor induction in tumor-bearing mice by exogenous/endogenous tumor necrosis factor therapy as compared with systemic administration of various biologic response modifiers. Mol. Biother., 3, 1991, 224-230.
12. REGAN, M.C., KIRK, S.J., HURSON, M., SODEYAMA, M., WASSERKRUG, H.L., BARBUL, A.: Tumor necrosis factor-α inhibits in vivo collagen synthesis. Surgery, 113, 1993, 173-177.
13. SCHMAUDER-CHOCK, E.A., CHOCK, S.P., PATCHEN, M.L.: Ultrastructural localization of tumour necrosis factor-alpha. Histochem. J., 26, 1994, 142-151.
14. SCHULZE-OSTHOFF, K., BAKKER, A.C., VANHAESEBROECK, B., BEYAERT, R., JACOB, W.A., FIERS, W.: Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. J. Biol. Chem., 267, 1992, 5317-5323.
15. SHEAR, M.J., PERRAULT., A.: Chemical treatment of tumors. IX. Reactions of mice with primary subcutaneous tumors to injection of hemorrhage-producing bacterial polysaccharide. J. Natl. Cancer Inst., 4, 1943, 416-468.
16. SHEPPARD, B.C., VENZON, D., FRAKER, D.L., LANGSTEIN, H.N., JENSEN, J.C., NORTON, J.A.: Prolonged survival of tumor-bearing rats with repetitive low-dose recombinant tumor necrosis factor. Cancer Res., 50, 1990, 3928-3933.
17. SHEPARD, M.H., LEWIS, G.D.: Resistance of tumor cells to tumor necrosis factor. J. Clin. Immunol., 8, 1988, 333-341.
18. SIDHU, R.S., BOLLON, A.P.: Tumor necrosis factor activities and cancer therapy - a perspective. Pharmacol. Ther., 57, 1993, 79-128.
19. TENG, M.N., PARK, B.H., KOEPPEN, H.K., TRACEY, K.J., FENDLY, B.M., SCHREIBER, H.: Long-term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T-cell immunity. Proc. Natl. Acad. Sci. USA, 88, 1991, 3535-3539.
20. TERLIKOWSKI, S., NOWAK, H.F.R., LOTOCKI, W.: Evaluation of biometric parameters of Morris hepatoma after application of human recombinant tumor necrosis factor. Neoplasma, 42, 1995, 83-87.
21. TERLIKOWSKI, S., NOWAK, H.F.R., LOTOCKI, W.: Inhibitory effect of the human recombinant tumor necrosis factor on the growth of Morris hepatoma in rats. Exp. Toxic. Pathol., 47, 1995, 81-87.
22. VASSALI, P.: The pathophysiology of tumor necrosis factor. Annu. Rev. Immunol., 10, 1992, 411-452.
23. WATANABE, N., NIITSU, Y., UMENO, H., KURIYAMA, H., NEDA, H., YAMAUCHI, N., MAEDA, M., URUSHIZAKI, I.: Toxic effect of tumor necrosis factor on tumor vasculature in mice. Cancer Res., 48, 1988, 2179-3183.